Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

43.30 +1.07 (+2.53%)
Streaming Delayed Price Updated: 3:09 PM EST, Feb 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
Via ACCESSWIRE
Dyadic International Inc. (DYAI): Bird Flu Vaccine Development Amid Rising Pandemic Concerns
Via AB Newswire
News headline image
Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting
Via ACCESSWIRE
News headline image
Moderna to Present at Upcoming Conferences in May/June 2024
Via ACCESSWIRE
News headline image
Will the Biotech Sector Shift From Lagger to Leader?
The biotech sector has experienced a significant rally after bouncing off uptrend support and is now consolidating near major SMAs. 
Via MarketBeat
Topics ETFs
News headline image
Moderna Announces Update on Investigational RSV Vaccine
Via ACCESSWIRE
News headline image
Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Via ACCESSWIRE
News headline image
Moderna and OpenAI Collaborate To Advance mRNA Medicine
Via ACCESSWIRE
Moderna Inc. (NASDAQ: MRNA) Leading the Way in Tuesday Trading Based on Percentage Gain
Via Investor Brand Network
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024
EQNX::TICKER_START (OTCPK:MUSLF),(CSE:MUSL),(NYSE:MRK),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:AZN) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Pfizer Finds a Foothold After a Solid Q1 2024 Earnings Report
After a painful two-year selloff, Pfizer shareholders may have finally gained a foothold after the company delivered a solid Q1 2024 earnings report 
Via MarketBeat
News headline image
Moderna Announces Contract with Brazil to Supply 12.5 million COVID-19 Vaccines as Part of National Vaccination Campaign
Via ACCESSWIRE
News headline image
Moderna to Present at Upcoming Investor Conferences in March 2024
Via ACCESSWIRE
News headline image
Moderna Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Updates
Via ACCESSWIRE
News headline image
Moderna Provides Business and Pipeline Updates at 42nd Annual J.P. Morgan Healthcare Conference
Via ACCESSWIRE
News headline image
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024
From FN Media Group LLC
Via GlobeNewswire
News headline image
Moderna to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024
Via ACCESSWIRE
Moderna Inc. (NASDAQ: MRNA) Highlighted for Surprising Price Action
Via Investor Brand Network
News headline image
Phase 1/2 Interim Data on Moderna’s mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia, Published in Nature
Via ACCESSWIRE
News headline image
Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials
Via ACCESSWIRE
News headline image
Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine
Via ACCESSWIRE
News headline image
Moderna to Host Fifth Annual Investor Event For Vaccines and Business Updates on March 27, 2024
Via ACCESSWIRE
News headline image
Novavax’s dispute resolution and upcoming earnings call
Novavax navigates legal settlements, earnings expectations, and competition, hoping their protein-based vaccines become a global health game-changer. 
Via MarketBeat
Topics Earnings
News headline image
Moderna Chief Executive Officer Stéphane Bancel Elected to National Academy of Engineering
Via ACCESSWIRE
News headline image
Moderna to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 22, 2024
Via ACCESSWIRE
News headline image
Moderna Named to Fortune's List of World's Most Admired Companies
Via ACCESSWIRE
News headline image
3 health care stocks off to strong starts in 2024
With the bullish news flow lately, the market has taken a liking to health care stocks in recent weeks - including these three early 2024 gainers. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Are defensive sectors ready to outshine growth in 2024?
Is 2024 the year defensive stocks rotate into leadership? As the year gets underway, defensives such as healthcare, energy, utilities and consumer staples lead. 
Via MarketBeat
News headline image
MarketBeat Week in Review – 1/1 - 1/5
Stocks finished the week looking for direction after a hotter-than-expected Jobs report and as investors wait for inflation information and big bank earnings 
Via MarketBeat
Topics Economy
News headline image
3 reasons 2024 Moderna shareholders may party like it's 2021
With interest in Moderna Inc. stock picking up alongside news flow, investors could be in for some very healthy 2024 gains. 
Via MarketBeat
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.